Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.
about
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisEuropean Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment.Quantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor CriterionA critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers.Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteriaDiagnostic usefulness of the Janus kinase 2 mutation in non BCR/ABL myeloproliferative disorders.WHO classification of myeloproliferative neoplasms (MPN): A critical update.Rethinking the diagnostic criteria of polycythemia vera.Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.Myeloproliferative neoplasms: Morphology and clinical practice.European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.Masked polycythemia vera (mPV): results of an international study.The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.Masked polycythemia vera diagnosed according to WHO and BCSH classification.Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.
P2860
Q26772881-14A3502C-1A6E-4223-B33C-3C9A254C9FDCQ35794393-D6EE9938-F47C-4E96-8736-70AD9C81BA9EQ36182119-9C25B472-3A21-4936-8062-50D7E4B5DDBEQ36362041-FE859FA9-9154-433A-9491-AF64A7E3DD0CQ36634607-9BB3CD33-FB35-4CA1-BBDF-BB921DF46773Q36857937-9EA2D0D9-FC6D-42FA-BEA3-EE7AE0B90625Q36857941-9D59DDF1-AA0C-44D0-BCDE-CFC151507127Q36874807-0E1A3B22-2C37-4DFD-8E8B-3A9D33DDFDDAQ37475716-EE4644CF-820F-4D16-8C42-02DD5BDC9B6FQ38154519-A043A4E8-18F2-43E1-9020-179D9A07D394Q38172388-5A4AD7F7-D92C-4FE6-8246-D0E51603C6D3Q38187675-76159DFA-F40A-4516-877D-A99D2B328210Q38683559-AD0312FE-0124-4EDD-8FE8-42E474E39D4CQ38689790-F256D34C-D60C-41DB-945D-9E2CDC29A2B4Q45892294-A88EB716-EC93-403A-99C0-C9B73412135EQ46731979-0AC0F77C-E40B-4282-A59A-150AF6A64203Q49633536-ED336160-F0CF-4DC0-AC8D-CE8D59946275Q54329508-93C6D4AE-ED57-43A5-97F5-7DD1EB3E56C1Q54376493-4E2BE0CA-FD26-43A9-87C9-27B617B1463CQ54400423-58B3961A-C995-4C7E-8B0D-CAD38B5EC96FQ54452862-C274683A-5439-4F6A-A76E-1D6D433758CE
P2860
Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Initial (latent) polycythemia ...... ing essential thrombocythemia.
@en
type
label
Initial (latent) polycythemia ...... ing essential thrombocythemia.
@en
prefLabel
Initial (latent) polycythemia ...... ing essential thrombocythemia.
@en
P2093
P2860
P356
P1433
P1476
Initial (latent) polycythemia ...... ing essential thrombocythemia.
@en
P2093
Hans Michael Kvasnicka
Jurgen Thiele
Volker Diehl
P2860
P304
P356
10.1159/000084673
P577
2005-01-01T00:00:00Z